Posts Categorized: Schizophrenia

Exciting Recent Paper on Inflammation and Nrf2

Long time Center member Dr. Dinkova-Kostova participated in research described in a very exciting paper in Nature that she co-authored along with a large team of colleagues from Harvard (US), Trinity College (Ireland), the Universities of Dundee, Cambridge, and Glascow (all UK), and elsewhere. Their study describes discovery of a Krebs cycle derivative that is a crucial anti-inflammatory metabolite which also regulates type… Read more »

New Study from Korea: Sulforaphane Has Positive Effects in a Mouse Model of Alzheimer’s Disease

Sulforaphane, was isolated by us from broccoli and broccoli sprouts many years ago.  It was developed by us and many others around the world as a chemoprotective phytochemical — a compound from plants that is not required for life (like proteins, carbohydrates, fats, vitamins and minerals), but which enhances health.  Many laboratory and animal studies… Read more »

New study indicates ability of oral sulforaphane to boost antioxidant response in the human brain

Our Center participated in a study with results ​just​ published ​i​n Molecular Neuropsychiatry.  This small pilot study was led by colleagues in ​The Schizophrenia Center​, along with the Departments of Psychiatry and Radiology at the Johns Hopkins School of Medicine.  Nine healthy volunteers ingested sulforaphane from broccoli​, daily for seven days.  There were increases ​in​ glutathione​ (the body’s most abundant antioxidant)​ in the blood, and in the… Read more »